ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our study indicated that SMO antagonist vismodegib induced autophagy in several BCR-ABL+ CML cell lines, including K562 and BaF3 cell lines harboring the T315I mutation of BCR-ABL fusion gene (BCR-ABL) (an infamous drug resistance mutation in CML).